NN1845 / Novo Nordisk - LARVOL DELTA

A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works (clinicaltrials.gov) - P1 | N=30 | Completed | Sponsor: Novo Nordisk A/S | Recruiting ➔ Completed

Trial completion • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

"The main achievement at the moment is waiting for @novonordisk - glucose-sensitive insulin "NNC0363-0845". Stage 1 of clinical trials was supposed to end today, but there is no news yet (" (@A_e_s_h)

Clinical

"2. For example, your NNC0363-0845. Look forward to!" (@A_e_s_h)

A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works (clinicaltrials.gov) - P1; N=30; Recruiting; Sponsor: Novo Nordisk A/S; Not yet recruiting ➔ Recruiting

Enrollment open • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works (clinicaltrials.gov) - P1; N=30; Not yet recruiting; Sponsor: Novo Nordisk A/S

New P1 trial • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes (clinicaltrials.gov) - P1; N=68; Completed; Sponsor: Novo Nordisk A/S; Recruiting ➔ Completed

Trial completion • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes (clinicaltrials.gov) - P1; N=78; Recruiting; Sponsor: Novo Nordisk A/S; Trial completion date: Mar 2021 ➔ Jul 2021; Trial primary completion date: Mar 2021 ➔ Jul 2021

Clinical • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes (clinicaltrials.gov) - P1; N=78; Recruiting; Sponsor: Novo Nordisk A/S; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes (clinicaltrials.gov) - P1; N=78; Not yet recruiting; Sponsor: Novo Nordisk A/S

Clinical • New P1 trial • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus